MedPath

SPG-601

Generic Name
SPG-601

Study of SPG601 in Adult Men With Fragile X Syndrome

Phase 2
Completed
Conditions
Fragile X Syndrome
Interventions
Drug: Placebo
First Posted Date
2024-05-14
Last Posted Date
2025-01-14
Lead Sponsor
Spinogenix
Target Recruit Count
10
Registration Number
NCT06413537
Locations
🇺🇸

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath